Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network
Authors:
- Tze-Wen ChungTCTze-Wen Chung
- Shyr-Yi LinSLShyr-Yi Lin
- Der-Zen LiuDLDer-Zen Liu
- Yu-Chang TyanYTYu-Chang Tyan
- Juin-Sen YangJYJuin-Sen Yang
- 1 December 2009
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 382 (1-2) , 39-44
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulationEuropean Journal of Pharmaceutical Sciences, 2008
- Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticlesBiomaterials, 2008
- A Review of Poloxamer 407 Pharmaceutical and Pharmacological CharacteristicsPharmaceutical Research, 2006
- Preparation, characterization, swelling and in vitro drug release behaviour of poly[N-acryloylglycine-chitosan] interpolymeric pH and thermally-responsive hydrogelsEuropean Polymer Journal, 2005
- Synthesis and characterization of Pluronic® grafted chitosan copolymer as a novel injectable biomaterialCurrent Applied Physics, 2005
- Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitroInternational Journal of Pharmaceutics, 2003
- Thermosensitive sol–gel reversible hydrogelsAdvanced Drug Delivery Reviews, 2002
- Intratumoral Administration of Paclitaxel in an In Situ Gelling Poloxamer 407 FormulationPharmaceutical Development and Technology, 2002
- Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in ratsInternational Journal of Pharmaceutics, 1999
- Diffusion of rat atrial natriuretic factor in thermoreversible poloxamer gelsBiomaterials, 1989